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MiceFibroblast growth factor-23 (FGF23) is a bone-derived endocrine regulator of phosphate homeostasis which
inhibits renal tubular phosphate reabsorption. Binding of circulating FGF23 to FGF receptors in the cell
membrane requires the concurrent presence of the co-receptor αKlotho. It is still controversial whether
αKlotho is expressed in the kidney proximal tubule, the principal site of phosphate reabsorption. Hence, it
has remained an enigma as to how FGF23 downregulates renal phosphate reabsorption. Here, we show
that renal proximal tubular cells do express the co-receptor αKlotho together with cognate FGF receptors,
and that FGF23 directly downregulates membrane expression of the sodium-phosphate cotransporter
NaPi-2a by serine phosphorylation of the scaffolding protein Na+/H+ exchange regulatory cofactor (NHERF)-1
through ERK1/2 and serum/glucocorticoid-regulated kinase-1 signaling.
© 2012 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Fibroblast growth factor-23 (FGF23)was discovered as a phosphaturic
hormone through genetic studies in patients suffering from autosomal
dominant hypophosphatemic rickets, a renal phosphate wasting disease
[1]. FGF23 is secreted by osteocytes and osteoblasts in bone in response
to elevated phosphate and vitamin D, and acts mainly on the kidney to
down-regulate renal tubular phosphate reuptake and 1α-hydroxylase
expression as part of a negative feedback loop between bone and kidney
[2]. The down-regulation of 1α-hydroxylase expression suppresses
production of the biologically active vitamin D hormone, 1α,25-
dihydroxyvitaminD3. Although the renal effects of FGF23 arewell charac-
terized at thewhole organ level, themolecularmechanismunderlying the
phosphaturic action of FGF23 has remained elusive.
Cellular signaling of FGF23 requires the concurrent presence of
FGF receptors (FGFRs) and the transmembrane protein αKlotho,
which functions as a co-receptor [3]. While FGFRs are ubiquitously
expressed, αKlotho expression is restricted to few tissues and hencethophysiology and Biophysics,
Medicine, Veterinaerplatz 1,
.G. Erben).
-NC-ND license.targets the endocrine actions of circulating FGF23 to speciﬁc tissues.
In the kidney, Klotho is expressed mainly in the distal tubule [4],
but the major site of regulation of phosphate excretion is the proxi-
mal tubule. Although earlier in vitro microperfusion experiments
with isolated rabbit proximal tubules suggested a possible direct ef-
fect of FGF23 on the proximal tubule [5], the current dogma is that
FGF23 acts on the distal tubule, generating an unknown endocrine
or paracrine secondary signal that in turn signals back to the proximal
tubule to lower apical membrane expression of the sodium-
phosphate cotransporters type 2a (NaPi-2a) and 2c (NaPi-2c) [6,7]
that primarily mediate renal tubular phosphate reabsorption. A re-
cent study, however, suggested that αKlotho may be expressed at
low levels also in the proximal tubule, and that αKlotho may itself
be a phosphaturic hormone [8]. The extracellular domain of αKlotho
can be shed from the cell surface and released into the blood circula-
tion, and it is thought that this secreted form ofαKlothomay have the
ability to alter the function and abundance of membrane glycopro-
teins such as NaPi-2a by removing sialic acid or other terminal sugars
from sugar chains through a putative glycosidase activity [8–10].
Itwas the aim of the current study to elucidate further themolecular
mechanism underlying the phosphaturic action of FGF23. Here, we
show that murine proximal tubular epithelium expresses αKlotho,
and that FGF23 acts directly on proximal tubules to downregulate
membrane expression of NaPi-2a via activation of ERK1/2 and serum/
glucocorticoid-regulated kinase-1 (SGK1).
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Animals
All animal studies were approved by the Ethical Committee of the
University of Veterinary Medicine, Vienna, and by the Austrian Federal
Ministry of Science and Research. Wild-type C57BL/6 mice were bred
in our in-house animal facility, and were kept at 24 °C with a 12 hour/
12 hour light/dark cycle with free access to a normal mouse chow
(Ssniff, Soest, Germany) and tap water.
For some additional experiments, wild-type mice, mice with a non-
functioning vitamin D receptor (VDRΔ/Δ), and compound mutants
deﬁcient in VDR and Klotho (Kl−/−/VDRΔ/Δ) were generated by
intercrossing VDR+/Δ/Kl+/− double heterozygous animals, and were
genotyped as described earlier [11]. To normalize mineral homeostasis
in VDRΔ/Δ and Kl−/−/VDRΔ/Δmice [11], all genotypes were fed a rescue
diet (Ssniff, Soest, Germany)which contained 2.0% calcium, 1.25%phos-
phorus, 20% lactose and 600 IU vitamin D/kg, starting from 16 days of
age.
Laser capture microdissection (LCM)
Kidney cryosections were prepared from snap-frozen tissues.
Proximal and distal tubules were harvested using a Veritas (Arcturus)
LCM system. RNA was extracted using the PicoPure RNA isolation kit
(Qiagen).
qRT-PCR
RNA purity and integrity were determined with a bioanalyzer
(Agilent). Reverse transcription was performed using iScript™ cDNA
Synthesis Kit (Bio-Rad). Real-time PCR was performed in duplicate on
a Rotor-Gene™ 6000 cycler (Corbett Life Science) using QuantiFast™
SYBR® Green PCR Kit (Qiagen). RT-minus samples served as a control
to exclude ampliﬁcation from genomic DNA, and amplicon melting
analysis was performed to exclude primer dimerization and unspeciﬁc
ampliﬁcation. β2‐Microglobulin was used as house-keeping gene for
normalization of the mRNA expression data. N-fold change in gene ex-
pression was calculated using the Pfafﬂmodel [12].
Isolation and culture of renal proximal tubular cells
Primary mouse proximal tubular epithelial cells were isolated
from C57BL/6 mice according to previously established protocols
by collagenase digestion and density gradient centrifugation, and
cultured in serum-free, hormonally deﬁned culture medium [13,14].
Purity of proximal tubular cells was examined by qRT-PCR analysis
of calbindin D28k, transient receptor potential vanilloid-5 (TRPV5),
and NaPi2a mRNA.
Isolation of renal proximal tubular segments
Renal proximal tubules were isolated as reported previously
[15–17]. In brief, murine kidneys were perfused with sterile culture
medium (Ham's F12; GIBCO) containing 1 mg/ml collagenase (type
II; Sigma) and 1 mg/ml pronase E (type XXV, Sigma) at pH 7.4 and
37 °C. The cortical tissue was dissected in small pieces and placed at
37 °C in sterile Ham's F12 medium containing 0.5 mg/ml collagenase
II and 0.5 mg/ml pronase E for 15 min with vigorous shaking. After
centrifugation at 3000 rpm for 4 min, the enzyme-containing solution
was removed, and tubules were resuspended in ice-cold medium
containing 1% antibiotic/antimycotic and placed on ice. Individual
proximal tubule segments were identiﬁed based on morphology in
a dissection microscope at ×25–40 magniﬁcation by their appearance
and dimensions.In vitro experiments with proximal tubular cells and segments
In vitro experiments with cultured proximal tubular cells and dis-
sected tubular segments were performed in serum-free, hormonally
deﬁned culture medium at 37 °C in 5% CO2 [13,14]. Proximal tubular
cells were incubated with 1–100 ng/ml of recombinant human
FGF23 R176/179Q (rFGF23) [18] for 0.5, 1, 2, and 4 h. Proximal tubu-
lar segments were incubated with rFGF23 (100 ng/ml), 10 ng/ml of
the SGK1 kinase inhibitor GSK 650394 (Axon Medchem) or 10 ng/ml
of the ERK1/2 inhibitor PD184352 (Sigma) alone or in combination
with rFGF23, or 10−8 M hPTH(1–34) (Bachem) for 1, 2 and 4 h. For
co-immunoprecipitation experiments, proximal tubular segments
were incubated with rFGF23 (100 ng/ml) or 10−8 M hPTH(1–34),
alone or in combination with 10 ng/ml of GSK 650394 for 2 h. To assess
the Klotho dependency of the effects of FGF23, proximal tubular seg-
ments from 3-month-old wild-type, VDRΔ/Δ, and Kl−/−/VDRΔ/Δ mice
were incubated with 1–100 ng/ml rFGF23 for 2 h. Protein samples for
Western blotting analysis or co-immunoprecipitation were collected
in lysis buffer.
In vivo experiments
Four-month-oldmale C57BL/6 mice received a single intraperitone-
al injection of vehicle (phosphate-buffered saline with 2% DMSO) or
rFGF23 (10 μg per mouse). Spontaneous urine was collected before
and 8 h after injection of rFGF23. Eight hours post-injection, the mice
were killed by exsanguination from the abdominal V. cava under anes-
thesia with ketamine/xylazine (67/7 mg/kg i.p.). Serum phosphorus
was analyzed on a Hitachi 912 Autoanalyzer (Boehringer Mannheim),
urinary phosphorus and urinary creatinine were measured on a Cobas
c111 analyzer (Roche). Kidney cortices were immediately dissected in
ice-cold isolation buffer after being removed from animals and then ho-
mogenized using a Potter–Elvehjem homogenizer at 4 °C. Brush border
membrane vesicles (BBMV) were prepared using three consecutive
magnesium precipitations (15 mM), and solubilized in Laemmli sample
buffer forWestern blotting. To verify BBMpurity, the activity of the BBM
enzyme alkaline phosphatase and leucine aminopeptidase was regular-
ly monitored in BBM fractions.
Western blotting
Protein samples were fractionated on SDS-PAGE (50 μg/well) and
transferred to a nitrocellulose membrane (Thermo Scientiﬁc). Immuno-
blotswere incubated overnight at 4 °Cwith primary antibodies including
anti-NaPi-2a (generous gift of Drs. Jürg Biber andHeiniMurer, University
of Zurich), anti-total-ERK1/2 (BD Biosciences), anti-phospho-ERK1/2
(Cell Signaling), anti-total-SGK1 (Applied Biosystems), anti-phospho-
SGK1 (Santa Cruz Biotechnology), anti-αKlotho (Alpha Diagnostics,
1:1000), or anti-β-actin (Sigma) antibody in 2% (w/v) bovine serum
albumin (BSA, Sigma) in a TBS-T buffer [150 mM NaCl, 10 mM Tris
(pH 7.4/HCl), 0.2% (v/v) Tween-20]. After washing, membranes were in-
cubated with horseradish peroxidase-conjugated secondary antibodies
(Amersham Life Sciences). Speciﬁc signal was visualized by ECL kit
(Amersham Life Sciences). The protein bands were quantiﬁed by Image
Quant 5.0 software (Molecular Dynamics). The expression levels were
normalized to Ponceau S stain. Expression levels of phospho-SGK1 and
phospho-ERK1/2 were normalized to total SGK1 and total ERK1/2 pro-
tein expression.
Co-immunoprecipitation
Homogenate protein samples of kidney cortex (1 mg) or dissected
proximal tubular segments (40 μg) were incubated with 2 μg of anti-
NHERF-1 (Abcam), anti-phosphoserine (Alpha Diagnostics), or anti-
NaPi-2a (generous gift of Drs. Jürg Biber and Heini Murer, University
of Zurich) antibody at 4 °C overnight. The immune complexes were
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(Santa Cruz Biotechnology), followed by overnight incubation at
4 °C with gentle rocking. The immunoprecipitates were collected by
centrifugation at 1000×g for 5 min at 4 °C and washed for 4 times
in PBS, each time repeating the centrifugation step. After the ﬁnal
wash, the pellets were suspended in 40 μl of electrophoresis sample
buffer and boiled for 2–3 min. Western blot analysis was performed
using primary anti-NHERF-1 or anti-NaPi-2a antibody.
Immunohistochemistry
For immunohistochemistry, 5-μm-thick parafﬁn sections of
paraformaldehyde-ﬁxed kidneys from untreated wild-type mice (for
anti-αKlotho staining), or from wild-type mice injected with rFGF23
(n=4) or vehicle (n=3) (for anti-NHERF-1 and anti-phosphoserine
staining) were prepared. Before immunoﬂuorescence staining, dewaxed
sections were pretreated with blocking solution containing 5% normalFig. 1. αKlotho is expressed in renal proximal tubules. (A)mRNA expression ofαKlotho, SGK1, c
renal proximal tubules (PT) anddistal tubules (DT) harvested from4mice by laser capturemicrod
relative to the expression levels in DT. Data are mean±SD. *Denotes Pb0.05 vs. DT by t-test. (B)
DAPI (blue), showing basolateralαKlotho staining pattern in distal and proximal tubules. Proxim
panel. Lower left andmiddle panels showH&E-stained parafﬁn sections for comparisonof subcell
tubule at higher magniﬁcation. Original magniﬁcation ×630. (C)Western blot analysis of Klotho
segments from wild-type mice. PT, proximal tubule; DT, distal tubule.goat serum in PBS with 0.1% bovine serum albumin and 0.3% Triton
X-100 for 60 min. All following stepswere performed in PBS containing
0.3% Triton X-100 and 5% normal goat serum.Without rinsing, sections
were incubated with polyclonal rabbit anti-αKlotho (Alpha Diagnos-
tics, 1:1000), or anti-NHERF-1 (Abcam, 1:300) and mouse monoclonal
anti-phosphoserine (Alpha Diagnostics, 1:1,000) antibodies at 4 °C
overnight. After washing, sections were incubated for 1.5 h with goat
anti-rabbit Alexa 548 (for αKlotho and for NHERF-1 detection) and
goat anti-mouse Alexa 488 (for P-Ser detection) secondary antibodies
(both from Invitrogen, diluted 1:400). Controls were performed by
omitting either one or both secondary antibodies. The slides were ana-
lyzed on a Zeiss LSM510Axioplan 2 confocalmicroscope equippedwith
a 63× oil immersion lens (NA 1.3). By use of themultitrack function, in-
dividual ﬂuorochromes were scanned with laser excitation at 488 and
543 nm separately with appropriate ﬁlter sets to avoid cross talk. Con-
trols were scannedwith identical laser excitation and ﬁlter settings. Pic-
tures were processed using Adobe Photoshop (overlays). Some mousealbindin D28k (Cal28k), TRPV5, and FGFR1–4 normalized to β2-microglobulin expression in
issection (LCM). For thepurpose of comparison,mRNA expression levels in PTwere plotted
Co-staining of parafﬁn sections frommurine kidneys with anti-αKlotho (red) antibody and
al tubule from inset in themerged image is shown at highermagniﬁcation in the lower right
ular localization. Lowermiddle panel (inset in lower left panel) showsH&E-stained proximal
protein expression normalized to β‐actin expression in isolated proximal and distal tubular
624 O. Andrukhova et al. / Bone 51 (2012) 621–628kidney parafﬁn sections were stained with hematoxylin and eosin
(H&E) by routine methods.
Statistical analyses
Statisticswere computed using SPSS forWindows 17.0. The datawere
analyzed by t-test for comparison of 2 groups, or analysis of variance
(ANOVA) followed by Student–Newman–Keuls (SNK) multiple compar-
ison test for comparison of more than 2 groups. P values of less than 0.05
were considered signiﬁcant. The data are presented as the mean±SD.
Results
αKlotho is expressed in renal proximal tubules
To address the questionwhether FGF23has a direct effect on the renal
proximal tubule,weﬁrstmeasuredmRNAexpression ofαKlotho in prox-
imal renal tubules harvested frommice by laser capture microdissection
(LCM), and compared the expression level to that found in distal tubules.
As shown in Fig. 1A,αKlotho is expressed in proximal tubules, albeit at an
approximately 2-fold lower level than that measured in distal tubules. InFig. 2. FGF23 directly activates ERK1/2–SGK1 signaling in proximal tubule epithelial cells. W
(phosphorylated and non-phosphorylated) ERK1/2 (tERK1/2) and SGK1 (tSGK1) in sample
treated for 0.5, 1, 2 and 4 h either with vehicle (Co) or 100 ng/ml recombinant FGF23 (rFG
(B). (C) Western blot analysis of pSGK1/tSGK1 ratio in proximal tubular segments treated
2 inhibitor (iERK1/2). The quantitative data are from 4 independent experiments each. Dataddition, LCM-harvested proximal tubules expressed FGFR1, 3, and 4, but
not 2 (Fig. 1A), in accordancewith earlier reports [19].Molecules typically
found in the distal tubule such as calbindinD28k or the transient receptor
potential vanilloid-5 (TRPV5) channelwere expressed at negligible levels
in proximal tubules (Fig. 1A), thereby conﬁrming that our results did not
relate to contamination of the proximal tubules by distal tubules. Immu-
nohistochemical staining of parafﬁn sections from murine kidneys
showed comparable expression ofαKlotho in proximal and distal tubules
(Fig. 1B, upper left panel).Moreover, themajor subcellular site ofαKlotho
protein expression appeared to be the basolateral membrane in both dis-
tal and proximal tubules (Fig. 1B, right panels). Western blot analysis of
proximal and distal tubular segments isolated from wild-type C57BL/6
mice showed similar Klotho protein expression in proximal and distal tu-
bules (Fig. 1C), conﬁrming the immunohistochemical results.
FGF23 directly activates ERK1/2 and SGK1 in proximal tubular epithelial
cells
It is known that FGFR activation by FGF23 leads to phosphorylation
of extracellular signal-regulated kinase 1/2 (ERK1/2) [3]. To examine
whether FGF23 directly activates FGFR in proximal tubular epithelium,estern blot analysis of phosphorylated ERK1/2 (pERK1/2) and SGK1 (pSGK1) and total
s of total protein isolated from cultured primary proximal tubular cells that had been
F23) (A), or for 2 h either with vehicle (Co) or with 1, 2.5, 10 or 100 ng/ml of rFGF23
for 2 h with vehicle (Co) or 100 ng/ml rFGF23 alone or in combination with an ERK1/
a are mean±SD. *Denotes Pb0.05 vs. control by ANOVA followed by SNK test.
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nant FGF23 (rFGF23), and analyzed ERK1/2 phosphorylation after cell
stimulation. rFGF23 time and dose dependently increased phosphoryla-
tion of ERK1/2 (Figs. 2A and B). In renal mouse cortical collecting duct
cells, it was shown that activation of ERK1/2 leads to downstream acti-
vation of SGK1 [20]. Since SGK1 is also expressed in proximal tubules
(Fig. 1A), we tested whether FGF23 can also activate SGK1 in proximal
tubular epithelium. Indeed, addition of rFGF23 to cultured proximal tu-
bular epithelial cells led to augmented phosphorylation of SGK1 in a
time and dose dependent fashion (Figs. 2A and B). Doses as low as
1 ng/ml rFGF23 clearly increased phospho-ERK1/2 and phospho-SGK1
in cultured proximal tubular epithelial cells after 2 h of incubation
(Fig. 2B). To test whether SGK1 is downstream of ERK1/2 activation,
we incubated isolated proximal tubular segments from wild-type
mice for 2 hwith rFGF23 alone or in combinationwith an ERK1/2 inhib-
itor. In the presence of an ERK1/2 inhibitor, rFGF23 did not increase
phosphorylation of SGK1, showing that activation of ERK1/2 by
rFGF23 leads to downstream activation of SGK1 (Fig. 2C).
FGF23 regulates NaPi-2a expression in proximal tubular segments
through SGK1
To examine whether FGF23 directly affects the membrane expres-
sion of NaPi-2a in the proximal tubule and whether SGK1 is a down-
stream mediator of this effect, we treated isolated proximal tubular
segments with rFGF23 alone or in combination with a SGK1 inhibitor.
Similar to parathyroid hormone (PTH), the other major phosphaturic
hormone, rFGF23 time dependently down-regulated NaPi2a protein
expression in the proximal tubular segments (Fig. 3). Notably, this ef-
fect of FGF23 was completely blocked by co-treatment of the tubular
segments with a SGK1 inhibitor.
FGF23 signaling reduces membrane abundance of the NaPi-2a/NHERF-1
complex in vivo and phosphorylates NHERF-1 via SGK1
PTH decreases membrane expression of NaPi-2a by phosphoryla-
tion of serine-77 (S77) in the Na+/H+ exchange regulatory cofactorFig. 3. FGF23 regulates NaPi-2a membrane expression in the proximal tubular segments
through SGK1 activation.Western blot analysis of NaPi-2a expression in isolated proximal
tubular segments treated with recombinant FGF23 (rFGF23), an SGK1 inhibitor (iSGK1),
or a mixture of rFGF23 and iSGK1. PTH was used as a positive control. The quantitative
data are from at least 4 independent experiments each. Data are mean±SD. *Denotes
Pb0.05 vs. control for the same time point by ANOVA followed by SNK test.(NHERF)-1, a scaffolding protein, leading to internalization and degrada-
tion of NaPi-2a [21,22]. A recent study suggested that the phosphaturic
action of FGF23 may also involve phosphorylation of NHERF-1 at S77
[23]. To test this possibility in vivo, we injected mice with rFGF23, and
performed reciprocal co-immunoprecipitation of the NaPi-2a/NHERF-1
complex on renal brush border membrane vesicle (BBMV) preparations.
rFGF23 caused an almost 4-fold increase in urinary phosphate excretion
compared to vehicle injection (46.9±10.4 vs. 12.3±0.6 mmol/mmol
creatinine in vehicle-treated controls, Pb0.05), and this effect was ac-
companied by hypophosphatemia (2.2±0.2 vs. 3.4±0.3 mmol/l in
vehicle-treated controls, Pb0.05). The rFGF23-induced phosphaturia
was associated with a 50% reduction in membrane abundance of the
NaPi-2a/NHERF-1 complex (Fig. 4A). Immunoﬂuorescence staining of
parafﬁn sections with anti-NHERF-1 and anti-phosphoserine antibodies
showed a clear reduction in the apical membrane abundance of
NHERF-1, and a general increase in serine phosphorylation in proximal
tubular epithelium of rFGF23-treated mice (Fig. 4B). Moreover, the co-
staining also suggested increased serine phosphorylation of NHERF-1
in the apical membrane, 8 h after rFGF23 injection (Fig. 4B). Collectively,
these data show that FGF23 signaling targets the NaPi-2a/NHERF-1 com-
plex in the apical cell membrane of renal tubular epithelium in vivo.
Next, we examined whether FGF23 induces phosphorylation of
NHERF-1 and whether SGK1 is involved in this process in isolated
proximal tubular segments. Similar to PTH, a 2-hour treatment of
proximal tubules with rFGF23 led to a marked increase in serine
phosphorylation of NHERF-1 (Fig. 4C). Importantly, FGF23- but not
PTH-induced phosphorylation of NHERF-1 could be completely
blocked by an SGK1 inhibitor (Fig. 4C), suggesting that activated
SGK1 mediates phosphorylation of NHERF-1.
FGF23 signaling in proximal tubules is Klotho dependent
To conﬁrm the functional role of Klotho in FGF23 signaling, we isolat-
ed proximal tubular segments from 3-month-oldwild-type, VDRΔ/Δ, and
Kl−/−/VDRΔ/Δmice, and treated them for 2 h with 1, 10, and 100 ng/ml
rFGF23 in vitro. We chose Kl−/−/VDRΔ/Δ mice as αKlotho deﬁcient ani-
mal model, because Kl−/− mice are characterized by severe alterations
inmineral homeostasis [11]whichmight affect the results of subsequent
ex vivo experiments. Kl−/−/VDRΔ/Δ mice on rescue diet are nor-
mocalcemic and normophosphatemic, and have unchanged PTH serum
levels compared with VDRΔ/Δmice [11]. rFGF23 treatment resulted in a
similar dose dependent down-regulation of NaPi-2a expression in prox-
imal tubular segments fromwild-type andVDRΔ/Δmice (Fig. 5), showing
that this effect is vitaminD independent. However, proximal tubular seg-
ments from Kl−/−/VDRΔ/Δ mice did not respond to 1 and 10 ng/ml
rFGF23, and showed a distinctly diminished response to the suppressive
effect of rFGF23 on NaPi-2a expression at 100 ng/ml, relative to wild-
type and VDRΔ/Δ mice. These results indicate that the direct effect of
FGF23 on NaPi-2a protein expression in proximal tubules is dependent
on the presence of Klotho at lower FGF23 concentrations, whereas
rFGF23 concentrations of greater than 10 ng/ml elicit Klotho indepen-
dent effects, at least to some extent.
Discussion
FGF23 is one of the most important endocrine regulators of phos-
phate metabolism. However, the molecular mechanism underlying
the phosphaturic action of FGF23 is still unknown. The current
study has shown 1) that αKlotho is expressed at the mRNA and pro-
tein level in proximal tubules together with FGFR1, 3, and 4, 2) that
FGF23 induces phosphorylation of ERK1/2 and SGK1 in cultured prox-
imal tubule cells, 3) that the FGF23-induced downregulation of NaPi-
2a expression in renal proximal tubular segments is SGK1 dependent,
4) that FGF23 signaling leads to serine phosphorylation of NHERF-1 in
proximal tubular segments, 5) that FGF23 reduces membrane abun-
dance of the NaPi-2a/NHERF-1 complex in vivo, and 6) that the
Fig. 4. FGF23 regulates renal proximal tubular membrane abundance of the NaPi-2a/NHERF-1 complex in vivo and leads to phosphorylation of NHERF-1 in vitro. (A) Reciprocal co-
immunoprecipitation (co-IP) of the NaPi-2a/NHERF-1 complex in BBMV preparations from recombinant FGF23- (rFGF23) and vehicle-treated mice (Veh, n=4 animals each). BBMVs
were isolated 8 h post-injection. WB: Western blot. Data are mean±SD. *Denotes Pb0.05 vs. vehicle control by t-test. (B) Co-staining of kidney parafﬁn sections with anti-
phosphoserine (green) and anti-NHERF-1 antibodies (red) from rFGF23- and vehicle-treated mice, 8 h post-injection. Original magniﬁcation ×630. (C) Immunoprecipitation (IP) of
serine-phosphorylated (P-Ser) proteins, followed byWestern blot analysis of NHERF-1, from isolated proximal tubular segments treated for 2 h with rFGF23, PTH, or iSGK1, or mixtures
of either rFGF23 or PTH plus iSGK1. Co, control; Veh, vehicle.
Fig. 5. FGF23-induced regulation of NaPi-2a membrane expression in proximal tubular
segments is Klotho dependent at lower concentrations. Western blot analysis of NaPi-2a
expression in proximal tubular segments isolated from 3-month-old wild-type, VDRΔ/Δ,
and Kl−/−/VDRΔ/Δ mice. Segments were treated for 2 h with 1–100 ng/ml recombinant
FGF23 (rFGF23) in vitro. The quantitative data are from at least 4 independent experi-
ments each. Data are mean±SD. *Denotes Pb0.05 vs. control within the same genotype
by ANOVA followed by SNK test.
626 O. Andrukhova et al. / Bone 51 (2012) 621–628presence of the co-receptor Klotho is essential for the FGF23-induced
downregulation of NaPi-2a expression in renal proximal tubular seg-
ments at near physiological concentrations.
Our data are in very good agreement with the study by Weinman
and coworkers [23]. The latter authors recently reported that FGF23
increases phosphorylation of ERK1/2 in cultured proximal tubular
cells. In addition, they showed that proximal tubular cells from
NHERF-1 null mice are resistant to the inhibitory action of FGF23 on
phosphate transport, and that proximal tubular cells from NHERF-1
null mice infected with a mutated form of the NHERF-1 protein
which cannot be phosphorylated at serine-77 do not respond to
FGF23 treatment. By using a different approach, our study provides
direct evidence that FGF23 induces phosphorylation of NHERF-1 in
isolated proximal tubular segments, which is probably the best in
vitro model of proximal tubular physiology because the cells stay in
their natural environment and do not lose polarity. In addition, we
show that FGF23 downregulates membrane abundance of NHERF-1
in vivo. Our ﬁnding that apical membrane abundance of NHERF-1
was profoundly reduced in mice 8 h after rFGF23 injection is in accor-
dance with the known fact that PTH-induced phosphorylation of
NHERF-1 leads to internalization and degradation of the NaPi-2a/
NHERF-1 complex [21,22]. Taken together, our study and the study
by Weinman et al. [23] provide compelling evidence that NHERF-1
is a downstream target of FGF23 signaling.
The current study suggests that FGF23 acts directly on proximal
tubular epithelium through its canonical, αKlotho and FGFR depen-
dent, signaling pathway. Moreover, we show for the ﬁrst time that
SGK1 is an essential component of the intracellular signaling cascade
leading to the FGF23-induced downregulation of NaPi-2a membrane
Fig. 6. Proposed model of FGF23 signaling in proximal tubular cells. FGF23 binds to the
FGFR1c-αKlotho complex and activates ERK1/2 kinase leading to SGK1 phosphoryla-
tion. SGK1 in turn phosphorylates NHERF-1, leading to internalization and degradation
of NaPi-2a. PTH signals through activation of PKA and PKC, which also leads to phos-
phorylation of NHERF-1. KL, αKlotho; PKA, protein kinase A; PKC, protein kinase C.
627O. Andrukhova et al. / Bone 51 (2012) 621–628expression. It is currently unknown whether NHERF-1 is directly
phosphorylated by activated SGK1. Since SGK1 can directly interact
with NHERF family proteins in the distal tubule [24], it is conceivable
that NHERF-1 is directly phosphorylated by SGK1 also in proximal
tubules.
It was previously thought that αKlotho is mainly expressed in the
distal tubule [4]. Earlier immunohistochemical studies using a rat
monoclonal anti-Klotho antibody on cryosections failed to detect
αKlotho in proximal tubules of mice [25]. In addition, Farrow and co-
workers [26] showed in a time course study that the earliest changes
in activation of ERK1/2 after injection of FGF23 in vivo in mice occur in
the distal tubules. Therefore, the current dogma is that FGF23 acts on
the distal tubule where it generates an unknown endocrine or para-
crine secondary signal that in turn signals back to the proximal tubule
to downregulate transcellular phosphate transport [6,7]. Hu et al. [8]
proposed an alternative hypothesis, namely that αKlotho itself may
be a phosphaturic hormone by altering the glycosylation pattern of
NaPi-2a integrated in the apical membrane through its putative enzy-
matic activity. The latter hypothesis requires the presence of αKlotho
at the apical cell membrane where NaPi-2a is expressed. However,
our study using a polyclonal rabbit antibody clearly showed that
αKlotho is expressed in proximal tubular epithelium, but mainly at
the basolateral membrane, suggesting that the major function of
αKlotho may be its function as a co-receptor for blood-borne FGF23.
The discrepant ﬁndings regarding αKlotho expression in the kidney
in our compared with earlier studies [25] may be explained by differ-
ences in the anti-Klotho antibodies used. If the phosphaturic action of
FGF23 is a direct effect on proximal tubules, how can it then be
explained that the earliest signaling events after injection of FGF23
in vivo occur in distal tubules [26]? Unpublished data (Andrukhova
et al.) from our laboratory have shown that FGF23 is also an impor-
tant regulator of the TRPV5 epithelial calcium channel in distal tu-
bules, suggesting that FGF23 may have parallel and independent
effects in proximal and distal renal tubules. The FGF23-induced sig-
naling events in distal renal tubules may occur faster than in proximal
tubules, explaining the ﬁndings by Farrow et al. [26].
A caveat of the current study is that we used a concentration of
100 ng/ml in most of our in vitro experiments. Faul and coworkers
[27] recently showed that FGF23 can signal in an αKlotho independent
fashion at concentration of 10 ng/ml and higher. In agreement with the
data of Faul et al. [27], we also found some Klotho independent activity
of 100 ng/ml rFGF23 to suppress NaPi-2a expression in proximal tubu-
lar segments in vitro. Therefore, although our in vivo data fully conﬁrm
our in vitroﬁndings,we cannot totally rule out the possibility ofαKlotho
independent effects induced by FGF23 signaling in most of our in vitro
studies. However, our experiments with proximal tubular segments
isolated from Kl−/−/VDRΔ/Δmice clearly showed that lower, near phys-
iological concentrations of FGF23 directly suppress NaPi-2a protein ex-
pression in proximal tubular epithelium in a Klotho dependentmanner.
Nevertheless, it is clear that additional experiments are necessary to
conﬁrm the FGF23-induced signaling pathways at physiological con-
centrations in renal proximal tubules.
We propose a model (Fig. 6) wherein FGF23 and PTH signaling
converge at the NaPi-2a/NHERF-1 complex, providing a molecular ex-
planation for the observed interaction between both signaling path-
ways in the regulation of proximal tubular phosphate reabsorption
in vitro [23] and in vivo (Andrukhova et al., unpublished). Taken to-
gether, our data show that FGF23 directly acts on proximal tubular
cells to down-regulate membrane abundance of NaPi-2a through
the ERK1/2–SGK1–NHERF-1 signaling axis. Hence, our data uncover
the long sought molecular mechanism of the phosphaturic action of
FGF23. Improved knowledge of the cellular mechanisms involved in
the phosphaturic action of FGF23 may open up new possibilities for
therapeutic intervention in phosphate-wasting disorders and other
diseases in which modulation of renal phosphate excretion is a ther-
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